Latest Phenothiazines Stories

2014-07-09 08:27:55

WOODCLIFF LAKE, N.J., July 9, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL. Fluphenazine decanoate injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics)....

2014-01-16 12:31:27

EATONTOWN, N.J., Jan. 16, 2014 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") announced the immediate availability of Prochlorperazine Edisylate Injection in the 5mg/mL strength. This product is the AP rated generic equivalent to the former brand Compazine and adds to Heritage's growing portfolio of generic injectable prescription products. According to IMS data for the twelve-months ended December 2013, the U.S. market for Prochlorperazine Edisylate Injection...

2011-06-24 12:46:41

A side effect of many commonly used drugs appears to increase the risks of both cognitive impairment and death in older people, according to new research led by the University of East Anglia (UEA). As part of the Medical Research Council's Cognitive Function and Ageing Studies (CFAS) project, the study is the first systematic investigation into the long term health impacts of 'anticholinergic activity' "“ a known potential side effect of many prescription and over the counter drugs...

2009-09-16 09:33:00

WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA's authority to require safety labeling changes, will highlight the risk of serious tissue injury when this drug is administered incorrectly. The agency is also alerting health care professionals to the new boxed warning for this product, which is used as a sedative...

2009-09-16 10:06:39

The U.S. Food and Drug Administration announced Wednesday it will require a boxed warning for the injectable form of the drug promethazine. FDA officials said the warning will highlight the risk of serious tissue injury when the drug is administered incorrectly. Promethazine is used as a sedative and to treat nausea and vomiting. Promethazine should neither be administered into an artery nor administered under the skin because of the risk of severe tissue injury, including gangrene, the FDA...

2009-03-04 13:06:12

The U.S. Supreme Court says a musician who lost an arm to gangrene has the right to sue pharmaceutical giant Wyeth over drug labeling. The 6-3 Supreme Court ruling said Diana Winn Levine of Vermont has the right to collect $6.7 million awarded by a jury after the drug maker was found guilty of inadequate labeling of the drug Phenergan, CNN reported Wednesday. The ruling is seen as a victory for groups seeking to hold the pharmaceutical industry accountable on drug safety. The anti-nausea...

2009-03-04 14:11:23

The U.S. Supreme Court ruled 6-3 Wednesday across ideological lines that federal law doesn't pre-empt state lawsuits for inadequate drug label warnings. The Bush administration had argued that the relatively mild federal law prevents such actions under tougher state laws and critics immediately said the decision would open the floodgates to a new round of drug label lawsuits. The case began when Diana Levine sought medical help for migraines. A Vermont clinic used injections of the...

2009-01-09 14:05:00

Antipsychotic drugs may result in an almost doubled risk of death in Alzheimer's patients, according to a study conducted by British researchers. The study, published Friday in the medical journal Lancet Neurology, supported previous notions that prolonged use of antipsychotic drugs can carry serious health risks, including Parkinson-like symptoms, sedation, chest infections, decline in brain function, stroke and death."For the vast majority of Alzheimer's patients, taking these drugs is...

2008-06-16 18:00:02

The U.S. Food and Drug Administration says it is ordering manufacturers of conventional antipsychotic drugs to include boxed warnings on the products. The FDA said it will require pharmaceutical companies to make safety-related changes to prescribing information and labeling to warn about an increased risk of death associated with the off-label use of the drugs when used to treat behavioral problems in older people with dementia. In 2005, the FDA announced similar labeling changes for...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'